Got Ideas For Reducing Industry's Regulatory Burden? FDA Wants To Know
This article was originally published in The Rose Sheet
Executive Summary
CFSAN and other FDA centers ask for "broad public comment" the agency will use "to guide our initial review of our regulations" required in President Trump's January executive order for federal agencies to "evaluate existing regulations and identify those that may merit repeal, replacement, or modification."